Comments

OptimizeRx

OPRXNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$10.20
0.191.90%
At Close: -
$10.20
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
OptimizeRx (OPRX) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$66.00
Lowest Price Target1
$13.00
Consensus Price Target1
$25.45

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

OptimizeRx (NASDAQ:OPRX) Stock, Analyst Ratings, Price Targets, Forecasts

OptimizeRx Corp has a consensus price target of $25.45 based on the ratings of 11 analysts. The high is $66 issued by Roth Capital on May 5, 2022. The low is $13 issued by Stifel on May 15, 2024. The 3 most-recent analyst ratings were released by JMP Securities on June 24, 2024, June 21, 2024, and May 15, 2024, respectively. With an average price target of $16 between JMP Securities, there's an implied 56.86% upside for OptimizeRx Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JMP Securities
Stifel
RBC Capital
Barclays
Lake Street

1calculated from analyst ratings

Analyst Ratings for OptimizeRx

Buy NowGet Alert
06/24/2024Buy Now56.86%JMP Securities
Constantine Davides
$16 → $16ReiteratesMarket Outperform → Market OutperformGet Alert
06/21/2024Buy Now56.86%JMP Securities
Constantine Davides
$16 → $16ReiteratesMarket Outperform → Market OutperformGet Alert
05/15/2024Buy Now56.86%JMP Securities
Constantine Davides
$15 → $16MaintainsMarket OutperformGet Alert
05/15/2024Buy Now27.45%Stifel
David Grossman
$13 → $13MaintainsBuyGet Alert
04/16/2024Buy Now47.06%JMP Securities
Constantine Davides
 → $15ReiteratesMarket Outperform → Market OutperformGet Alert
04/04/2024Buy Now47.06%JMP Securities
Constantine Davides
 → $15Initiates → Market OutperformGet Alert
04/01/2024Buy Now66.67%RBC Capital
Sean Dodge
 → $17ReiteratesOutperform → OutperformGet Alert
04/01/2024Buy Now27.45%Stifel
David Grossman
$13 → $13MaintainsBuyGet Alert
01/10/2024Buy Now66.67%RBC Capital
Sean Dodge
$14 → $17MaintainsOutperformGet Alert
01/03/2024Buy Now47.06%Barclays
Stephanie Davis
 → $15Initiates → Equal-WeightGet Alert
08/15/2023Buy Now37.25%RBC Capital
Sean Dodge
$18 → $14MaintainsOutperformGet Alert
08/15/2023Buy Now27.45%Lake Street
Eric Martinuzzi
$18 → $13MaintainsBuyGet Alert
08/15/2023Buy Now96.08%Roth MKM
Richard Baldry
$31 → $20MaintainsBuyGet Alert
08/15/2023Buy Now76.47%B. Riley Securities
Neil Chatterji
$28 → $18MaintainsBuyGet Alert
08/15/2023Buy Now27.45%Stifel
David Grossman
$16 → $13MaintainsBuyGet Alert
03/09/2023Buy Now76.47%RBC Capital
Sean Dodge
$22 → $18MaintainsOutperformGet Alert
02/02/2023Buy Now194.12%B. Riley Securities
Neil Chatterji
 → $30Reinstates → BuyGet Alert
11/01/2022Buy Now86.27%Stifel
David Grossman
 → $19Initiates → BuyGet Alert
10/31/2022Buy Now86.27%Stifel
David Grossman
 → $19Initiates → BuyGet Alert
08/10/2022Buy Now115.69%RBC Capital
Sean Dodge
$50 → $22MaintainsOutperformGet Alert
08/10/2022Buy Now56.86%Piper Sandler
Jeff Garro
$29 → $16MaintainsNeutralGet Alert
08/10/2022Buy Now194.12%SVB Leerink
Joy Zhang
$38 → $30MaintainsOutperformGet Alert
07/20/2022Buy Now449.02%B. Riley Securities
Marc Wiesenberger
$71 → $56MaintainsBuyGet Alert
07/15/2022Buy Now272.55%SVB Leerink
Joy Zhang
 → $38Initiates → OutperformGet Alert
07/01/2022Buy Now184.31%Piper Sandler
Jeff Garro
 → $29Initiates → NeutralGet Alert
05/05/2022Buy Now390.2%RBC Capital
Sean Dodge
$100 → $50MaintainsOutperformGet Alert
05/05/2022Buy Now547.06%Roth Capital
Richard Baldry
$112 → $66MaintainsBuyGet Alert
02/16/2022Buy Now645.1%Lake Street
Eric Martinuzzi
$98 → $76MaintainsBuyGet Alert
11/10/2021Buy Now880.39%RBC Capital
Sean Dodge
—MaintainsOutperformGet Alert

FAQ

Q

What is the target price for OptimizeRx (OPRX) stock?

A

The latest price target for OptimizeRx (NASDAQ:OPRX) was reported by JMP Securities on June 24, 2024. The analyst firm set a price target for $16.00 expecting OPRX to rise to within 12 months (a possible 56.86% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for OptimizeRx (OPRX)?

A

The latest analyst rating for OptimizeRx (NASDAQ:OPRX) was provided by JMP Securities, and OptimizeRx reiterated their market outperform rating.

Q

When was the last upgrade for OptimizeRx (OPRX)?

A

There is no last upgrade for OptimizeRx

Q

When was the last downgrade for OptimizeRx (OPRX)?

A

There is no last downgrade for OptimizeRx.

Q

When is the next analyst rating going to be posted or updated for OptimizeRx (OPRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptimizeRx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptimizeRx was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.

Q

Is the Analyst Rating OptimizeRx (OPRX) correct?

A

While ratings are subjective and will change, the latest OptimizeRx (OPRX) rating was a reiterated with a price target of $16.00 to $16.00. The current price OptimizeRx (OPRX) is trading at is $10.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch